Diabetes
Conference Coverage
EASD 2023: A deeper dive into type 1 and type 2 diabetes
“We always come after [the ADA annual meeting]. That puts us in a position where we can take deeper dives into the data. ... EASD is a calmer...
From the Journals
Weekly insulin with dosing app beneficial in type 2 diabetes
“Once-weekly icodec with a dosing guide app could conceivably address several challenges seen in everyday practice.”
From the Journals
Are vitamin D levels key to canagliflozin’s fracture risk?
“Something as simple as OTC vitamin D might protect against bone fractures caused by chronic multiyear treatment with a drug.”
Conference Coverage
Tirzepatide superior to semaglutide for A1c control, weight loss
“Although the efficacy of the high tirzepatide dose might make it a favorable choice, its real-world application can be affected on an individual’...
Conference Coverage
Echocardiography boosts prognostic power in T1D
“MPI has been around for many years, but our technique is rather novel” and has high intra- and inter-observer reproducibility. “It’s highly...
News from the FDA/CDC
FDA panel rejects implanted GLP1-RA dosing device for T2D
“The data show concerning safety signals that need further investigation.”
From the Journals
Exercise timing may dictate obesity, type 2 diabetes risk
People who exercised in the morning had a lower body mass index than those who exercised at other times, even though they were more sedentary.
Commentary
Beyond A1c: Implementing the new ESC 2023 guidelines
Controversially, the updated ESC guidance suggests the use of metformin only in patients with type 2 diabetes and atherosclerotic cardiovascular...
Conference Coverage
Islet, kidney transplants boost survival in type 1 diabetes
“Although islet transplantation has previously been shown to improve glycemic control, compared with conventional insulin therapy in recent...
Commentary
Smartphones for children with type 1 diabetes: Cause for concern?
As health care professionals, we owe it to our patients to discuss the ups and downs of technology with our patients. We can’t ostrich our way...
From the Journals
COVID booster may transiently raise glucose levels in T1D
“Clinicians, pharmacists, and other health care providers may need to counsel people with T1D to be more vigilant with glucose testing and insulin...